Scholarlink

<p>Mucosal melanoma (MM) is a rare and aggressive melanoma subtype with poor outcomes and poorly understood risk factors, including the contribution of germline pathogenic variants (PVs). In this study, 346 MM patients treated at MD Anderson Cancer Center underwent germline sequencing of 322 known cancer susceptibility genes, with PV frequencies compared to population controls (gnomAD and TOPMed) using Fisher’s exact test. The cohort had a median age at diagnosis of 64 years and was predominantly female (62%) and White (84.0%). Anatomical subtypes of MM included gastrointestinal (36%), head and neck (33%), and genitourinary (31%). Among patients with somatic testing results (<i>n</i> = 303), <i>KIT</i> mutations (26%) were most common, followed by <i>NRAS</i> (17%), <i>BRAF</i><sup><i>Non-V600</i></sup> (6.6%), and <i>BRAF</i><sup><i>V600</i></sup> (2.6%). Germline PVs were identified in 37 patients (10.7%), most frequently in <i>CHEK2</i> (<i>n</i> = 9, 23.0%), <i>ATM</i> (<i>n</i> = 8, 20.5%), and <i>MITF</i> (<i>n</i> = 6, 15.4%). <i>MITF</i> p.E318K (OR 6.0; 95% CI 2.2–13.2) and <i>CHEK2</i> c.1100delC (OR 6.7; 95% CI 1.8–17.5) were significantly enriched compared to population control rates. Patients with germline PVs were more likely to have two or more affected first-degree relatives (49.0% vs. 29.1%, <i>p</i> = 0.019). These findings highlight a meaningful germline contribution to MM risk and support the incorporation of genetic testing in this population.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Germline variants in cancer susceptibility genes among patients with mucosal melanoma

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年5月23日

查看全文
  • Afsaneh Amouzegar,
  • Xiaogang Wu,
  • James P. Long,
  • Gabriela W. Chen,
  • Justin W. Wong,
  • Sabitha Prabhakaran,
  • Latasha Little,
  • Curtis Gumbs,
  • Neus Bota,
  • Jared Malke,
  • Julie Simon,
  • Jianhua Zhang,
  • Priyadharsini Nagarajan,
  • Michael A. Davies,
  • Hussein Tawbi,
  • Rodabe N. Amaria,
  • Isabella C. Glitza Oliva,
  • Alexandra P. Ikeguchi,
  • Shirley Su,
  • Ehab Y. Hanna,
  • Roi Weiser,
  • Brian Bednarski,
  • Travis T. Sims,
  • Devarati Mitra,
  • Jennifer Wargo,
  • Jeffrey E. Gershenwald,
  • Paul Scheet,
  • Yao Yu,
  • Chad Huff,
  • Kelly C. Nelson,
  • Jennifer L. McQuade,
  • P. Andrew Futreal

摘要

Mucosal melanoma (MM) is a rare and aggressive melanoma subtype with poor outcomes and poorly understood risk factors, including the contribution of germline pathogenic variants (PVs). In this study, 346 MM patients treated at MD Anderson Cancer Center underwent germline sequencing of 322 known cancer susceptibility genes, with PV frequencies compared to population controls (gnomAD and TOPMed) using Fisher’s exact test. The cohort had a median age at diagnosis of 64 years and was predominantly female (62%) and White (84.0%). Anatomical subtypes of MM included gastrointestinal (36%), head and neck (33%), and genitourinary (31%). Among patients with somatic testing results (n = 303), KIT mutations (26%) were most common, followed by NRAS (17%), BRAFNon-V600 (6.6%), and BRAFV600 (2.6%). Germline PVs were identified in 37 patients (10.7%), most frequently in CHEK2 (n = 9, 23.0%), ATM (n = 8, 20.5%), and MITF (n = 6, 15.4%). MITF p.E318K (OR 6.0; 95% CI 2.2–13.2) and CHEK2 c.1100delC (OR 6.7; 95% CI 1.8–17.5) were significantly enriched compared to population control rates. Patients with germline PVs were more likely to have two or more affected first-degree relatives (49.0% vs. 29.1%, p = 0.019). These findings highlight a meaningful germline contribution to MM risk and support the incorporation of genetic testing in this population.